Members
HeLeNe Network members are principal investigators from Heidelberg area working on Hematology.
Members of the Heidelberg Leukemia Network
Dr. Daniel Mertens
DKFZ
Epigenetics for leukemia patient stratification and microenvironment as a therapeutic target
More Infos: www.dkfz.de
Dr. med. Tim Sauer
Heidelberg University Hospital
Chimeric Antigen Receptors (CARs) for the treatment of Acute myeloid leukemia (AML)
More Infos: www.klinikum.uni-heidelberg.de
Dr. Michael Milsom
DKFZ and HI-STEM
Molecular remodelling of normal HSCs during ageing, stress and leukemogenesis.
More Infos: www.dkfz.de
Dr. Stefanie Göllner
Heidelberg University Hospital
Epigenomics, Epitranscriptomics and novel therapy approaches in AML
More Infos: www.klinikum.uni-heidelberg.de
PD Dr. med. Simon Raffel
Heidelberg University Hospital
Metabolic Vulnerabilities of Acute Myeloid Leukemia Stem Cells
More Infos: www.klinikum.uni-heidelberg.de
PD Dr. med. Carolina Pabst
Heidelberg University Hospital
Identification of leukemia propagating genetic networks in primary human leukemic stem cells
More Infos: www.klinikum.uni-heidelberg.de
Priv.-Doz. Dr. med. Daniel Lipka
DKFZ and NCT
Cancer Epigenomics, Biomarker Discovery, Precision Oncology, Myeloid Neoplasms, Normal Hematopoiesis
More Infos: www.nct-heidelberg.de
Prof. Dr. Andreas Trumpp
HI-STEM and DKFZ
Hematopoietic and Leukemic Stem Cells, Therapy Resistance and Minimal Residual Disease (MRD)
More Infos: www.dkfz.de
Prof. Dr. Claudia Scholl
DKFZ and NCT Heidelberg
Discovery of functional dependencies in acute myeloid leukemia
More Infos: www.dkfz.de
Prof. Dr. Judith Zaugg
EMBL
Regulatory genomics and epigenetics to understand the contribution of the bone marrow niche on ageing and AML
More Infos: www.embl.org
Prof. Dr. Karsten Rippe
DKFZ
Chromatin networks in cancer tumor heterogeneity and therapy resistance
More Infos: www.dkfz.de
Prof. Dr. med. Carsten Müller-Tidow
Heidelberg University Hospital
Epigenomics, Epitranscriptomics and novel therapy approaches in AML
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. med. Michael Hundemer
Heidelberg University Hospital
Hematological Diagnostics, Development of new diagnostic approaches
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. med. Richard Schlenk
Heidelberg University Hospital and NCT
Clinical trials, innovative study designs, pharmacogenomics, measurable residual disease, liquid biopsies
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. med. Sascha Dietrich
Heidelberg University Hospital
An Integrated Systems Medicine Approach to Personalized and Targeted Therapy in Lymphoma
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. med. Alwin Krämer
Heidelberg University Hospital, DKFZ and NCT
Clonal heterogeneity and novel therapy approaches in AML
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. med. Stefan Fröhling
NCT and DKFZ
Cancer genomics, precision oncology, molecular pathogenesis and therapeutic targeting of myeloid neoplasms and bone and soft-tissue sarcoma
More Infos: www.klinikum.uni-heidelberg.de
Prof. Dr. Wolf-Karsten Hofmann
Heidelberg University, Medical Faculty Mannheim - University Medical Centre Mannheim
Myelodysplastic Syndrome, Myeloid Neoplasms, Molecular Genetics
More Infos: www.umm.uni-heidelberg.de